Compare Unichem Lab with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB PANACEA BIOTECH UNICHEM LAB/
PANACEA BIOTECH
 
P/E (TTM) x -46.4 13.2 - View Chart
P/BV x 1.1 5.1 22.1% View Chart
Dividend Yield % 1.2 0.0 -  

Financials

 UNICHEM LAB   PANACEA BIOTECH
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
PANACEA BIOTECH
Mar-19
UNICHEM LAB/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs292354 82.6%   
Low Rs182138 131.7%   
Sales per share (Unadj.) Rs167.774.6 224.9%  
Earnings per share (Unadj.) Rs-3.66.7 -54.4%  
Cash flow per share (Unadj.) Rs5.915.5 38.3%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.70-  
Book value per share (Unadj.) Rs372.357.2 650.7%  
Shares outstanding (eoy) m70.3861.25 114.9%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.43.3 42.9%   
Avg P/E ratio x-65.336.8 -177.3%  
P/CF ratio (eoy) x39.915.9 251.4%  
Price / Book Value ratio x0.64.3 14.8%  
Dividend payout %-110.20-   
Avg Mkt Cap Rs m16,68015,061 110.7%   
No. of employees `0002.62.3 112.4%   
Total wages/salary Rs m2,3931,471 162.7%   
Avg. sales/employee Rs Th4,535.21,973.6 229.8%   
Avg. wages/employee Rs Th919.8635.6 144.7%   
Avg. net profit/employee Rs Th-98.2176.8 -55.5%   
INCOME DATA
Net Sales Rs m11,8014,567 258.4%  
Other income Rs m98445 2,196.7%   
Total revenues Rs m12,7854,612 277.2%   
Gross profit Rs m-8352,030 -41.1%  
Depreciation Rs m674540 124.8%   
Interest Rs m751,048 7.2%   
Profit before tax Rs m-600486 -123.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-34377 -445.5%   
Profit after tax Rs m-256409 -62.5%  
Gross profit margin %-7.144.4 -15.9%  
Effective tax rate %57.315.9 361.2%   
Net profit margin %-2.29.0 -24.2%  
BALANCE SHEET DATA
Current assets Rs m20,3842,415 844.2%   
Current liabilities Rs m5,0299,077 55.4%   
Net working cap to sales %130.1-145.9 -89.2%  
Current ratio x4.10.3 1,523.8%  
Inventory Days Days10565 161.0%  
Debtors Days Days13571 190.2%  
Net fixed assets Rs m9,0238,333 108.3%   
Share capital Rs m14161 229.7%   
"Free" reserves Rs m26,0583,443 756.9%   
Net worth Rs m26,1993,504 747.7%   
Long term debt Rs m0461 0.0%   
Total assets Rs m31,49613,755 229.0%  
Interest coverage x-7.01.5 -476.5%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.40.3 112.8%   
Return on assets %-0.610.6 -5.4%  
Return on equity %-1.011.7 -8.4%  
Return on capital %-2.038.7 -5.2%  
Exports to sales %69.420.9 332.2%   
Imports to sales %08.1 0.0%   
Exports (fob) Rs m8,188954 858.4%   
Imports (cif) Rs mNA372 0.0%   
Fx inflow Rs m8,1881,203 680.6%   
Fx outflow Rs m596467 127.7%   
Net fx Rs m7,592736 1,031.0%   
CASH FLOW
From Operations Rs m-3,2781,049 -312.5%  
From Investments Rs m-2,860-54 5,346.0%  
From Financial Activity Rs m-24-1,011 2.4%  
Net Cashflow Rs m-4,690-20 23,808.1%  

Share Holding

Indian Promoters % 50.1 74.5 67.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.6 2,516.7%  
FIIs % 3.0 1.3 230.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 23.6 134.3%  
Shareholders   20,176 10,259 196.7%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   ALKEM LABORATORIES  STRIDES PHARMA SCIENCE  FDC  TORRENT PHARMA  DISHMAN PHARMA  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 244 Points Lower, Nifty Ends Below 14,300; UltraTech Cement & HCL Tech Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story(Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Top 3 Nifty ETFs to Buy Now(Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Apr 20, 2021 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS